Table 3 The characteristic of eighteen cases abnormally expressing CD54
Number | Subtype | Treatment status Before/After | Lymphoma cells expressing increased level of CD54/nucleated cells in BM (%) | CD54 MFIR |
|---|---|---|---|---|
1 | CLL/SLL | Before | 12.32 | 29.30 |
2 | MCL | After | 25.25 | 108.12 |
3 | MCL | Before | 0.13 | 47.69 |
4 | MCL | Before | 21.79 | 31.70 |
5 | MCL | After | 3.71 | 91.96 |
6 | MCL | Before | 21.28 | 131.19 |
7 | MCL | Before | 9.34 | 66.23 |
8 | MCL | Before | 4 | 38.21 |
9 | MCL | Before | 76.50 | 32.81 |
10 | MCL | After | 0.40 | 87.28 |
11 | FL | After | 9.78 | 35.06 |
12 | FL | After | 3.80 | 28.01 |
13 | MZL | Before | 0.18 | 99.71 |
14 | MZL | Before | 6.17 | 30.69 |
15 | MZL | Before | 2 | 52.63 |
16 | MZL | Before | 13.80 | 52.77 |
17 | MZL | After | 1.30 | 43.19 |
18 | HG-B-NHL | Before | 0.50 | 44.72 |